Nicholas Marshall, PhD, adds a diverse background in protein biochemistry, biophysical characterization, protein engineering, and process development to Invenra. As the leader of the Protein Sciences group, Nick oversees production and characterization of R&D phase molecules, including biophysical characterization and developability assessments of lead molecules. Nick brings more than 10 years of experience in therapeutic protein discovery and drug development. Prior to joining Invenra, Nick worked in Process Chemistry Research and Development at Merck (MSD), where he used directed evolution and high throughput methods to develop enzymes needed for biocatalytic synthesis of active pharmaceutical ingredients. Before Merck, Nick worked with Everett Stone and George Georgiou at the University of Texas at Austin to discover therapeutic enzymes for immune oncology. Nick holds a PhD in Chemical Biology from the University of Illinois where he studied electron transfer in proteins.